RENO, Nev., Aug. 4, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces that it will be stepping up the delivery of its home care applications for seniors and the disabled which it announced last year as a major product initiative. The ability to provide reliable monitoring and medical care for seniors in their home is expected to emerge as a major trend in the search for savings in the bloated US healthcare system.
The sudden reversal of spending patterns to follow new US budget cuts is certain to impact Medicare and Medicaid. These come at a time when demographic pressures of an ageing population make it increasingly difficult to continue providing easy access to a wide range of expensive medical facilities as in the past.
"We are seeing the emergence of a multi-billion dollar market for smart home care applications like ours that can not only monitor heart function, blood pressure, sugar levels, fever and oxygen source at home, but more importantly can also have it transmitted to a smart clinical system that will be reading the signs and providing suitable alerts in real time. These transmission protocols will require no human intervention and will be working through automated routes such as the GSM network," says Chairman Gerard Dab. "The ability to treat seniors at home will generate some of the serious savings required by policy makers."
The Company is already providing smart distributive and inferential technologies to healthcare providers. Provider organizations and their suppliers are part of a new generation of caregivers who will increasingly rely on our proprietary enabling platforms, real smart clinical tools and adapted mobile devices to improve ambulatory care and keep patients out of expensive hospital stays.
Consequently the Company has now revised its sales expectations in the home care market from one to three million dollars for Calendar 2012.
ABOUT VISUAL HEALTHCARE
Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications. They also include quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (NASDAQ OTC: VMCS), a leader in the field of Intelligent Electronic Health Records.
For more information, please visit: www.visualhealthcarecorp.com.
FORWARD- LOOKING STATEMENTS
Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.
Gerard Dab, CEO
Visual Healthcare Corp.
SOURCE Visual Healthcare Corp.